Suraksha Diagnostic Ltdは、最大1.92億株のOFSを含むIPOについてSEBIの承認を受けました。 Suraksha Diagnostic Ltd receives SEBI approval for an IPO involving an OFS of up to 1.92 crore equity shares.

コルカッタに本拠を置くスラクシャ・ダイアグノスティク株式会社は,セビから1.92億株の株式売却 (OFS) を含む初回公開取引 (IPO) の承認を得ており,その収益は完全に株主へ流出されます. Suraksha Diagnostic Ltd, based in Kolkata, has received approval from SEBI for an initial public offering (IPO) involving an Offer-for-Sale (OFS) of up to 1.92 crore equity shares, with proceeds going entirely to selling shareholders. この会社は統合病理学と放射線学のサービスを提供しており,インドのいくつかの州で約114万人の患者にサービスを提供しています. The company, which provides integrated pathology and radiology services, serves around 1.14 million patients across several Indian states. 株はボンベイ証券取引所と国立証券取引所に上場される. The shares will be listed on the Bombay Stock Exchange and National Stock Exchange.